CSPC Pharmaceutical Group Limited (CHJTF)
USD 0.65
(0.0%)
USD 0.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 31.45 Billion | 4.6 Billion | 4.3 Billion | 3.61 Billion | 3.21 Billion | 2.68 Billion |
| Cost of Revenue | 1.31 Billion | 1.29 Billion | 1.04 Billion | 906.75 Million | 901.13 Million | 902.43 Million |
| Gross Profit | 30.13 Billion | 3.31 Billion | 3.26 Billion | 2.7 Billion | 2.31 Billion | 1.78 Billion |
| Operating Expenses | 2.14 Billion | 2.3 Billion | 2.3 Billion | 1.92 Billion | 1.66 Billion | 1.24 Billion |
| Selling, General and Administrative Expenses | 1.46 Billion | 1.7 Billion | 1.77 Billion | 1.5 Billion | 1.37 Billion | 1.04 Billion |
| Research and Development Expenses | 683.36 Million | 593.43 Million | 530.48 Million | 418.79 Million | 291.11 Million | 202.21 Million |
| Other Expenses | - | 814.84 Million | 545.69 Million | - | - | - |
| Cost and Expenses | 31.45 Billion | 3.59 Billion | 3.34 Billion | 2.82 Billion | 2.56 Billion | 2.14 Billion |
| Operating Income | 7.01 Billion | 1.01 Billion | 965.15 Million | 787.5 Million | 647.58 Million | 539.17 Million |
| Interest Expense | 25.89 Million | 3.7 Million | 1.18 Million | 1.77 Million | 4.71 Million | 11.18 Million |
| Income Tax Expense | 186.27 Million | 200.99 Million | 179.11 Million | 168.39 Million | 129.92 Million | 111.5 Million |
| Earnings before Tax | 1.05 Billion | 1.13 Billion | 1.05 Billion | 924.23 Million | 664.73 Million | 574.96 Million |
| Net Income | 830.91 Million | 906.76 Million | 866.24 Million | 747.74 Million | 540.5 Million | 466.83 Million |
| Earnings Per Share Basic | 0.07 | 0.08 | 0.07 | 0.06 | 0.05 | 0.04 |
| Earnings Per Share Diluted | 0.07 | 0.08 | 0.07 | 0.06 | 0.05 | 0.04 |
| Weighted Average Shares Outstanding | 11.87 Billion | 11.91 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.98 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.87 Billion | 11.91 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.98 Billion |
| Gross Margin | 0.96 | 0.72 | 0.76 | 0.75 | 0.72 | 0.66 |
| EBIT Margin | 0.04 | 0.25 | 0.26 | 0.25 | 0.23 | 0.24 |
| Profit Margin | 0.03 | 0.20 | 0.20 | 0.21 | 0.17 | 0.17 |
| EBITDA | 1.14 Billion | 1.29 Billion | 1.18 Billion | 1.04 Billion | 5.35 Billion | 632.08 Million |
| Earnings Before Tax Margin | 0.22 | 0.22 | 0.22 | 0.22 | 0.20 | 0.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.3 Billion | 8.98 Billion | 4.44 Billion | 7.58 Billion | 7.78 Billion | 2.32 Billion |
| Cost of Revenue | 2.14 Billion | 2.48 Billion | 1.31 Billion | 2.2 Billion | 2.23 Billion | 698.69 Million |
| Gross Profit | 5.15 Billion | 6.49 Billion | 3.13 Billion | 5.38 Billion | 5.55 Billion | 1.62 Billion |
| Operating Expenses | 3.49 Billion | 4.46 Billion | 2.14 Billion | 3.59 Billion | 3.76 Billion | 1.11 Billion |
| Selling, General and Administrative Expenses | 2.11 Billion | 3.29 Billion | - | 2.44 Billion | 2.44 Billion | 785.81 Million |
| Research and Development Expenses | 1.37 Billion | 1.16 Billion | - | 1.15 Billion | 1.37 Billion | 332.35 Million |
| Other Expenses | - | - | 420.59 Million | 14.71 Million | 136.93 Million | 210.43 Million |
| Cost and Expenses | 5.63 Billion | 6.94 Billion | 3.45 Billion | 5.79 Billion | 6 Billion | 1.81 Billion |
| Operating Income | 1.66 Billion | 2.03 Billion | 990.43 Million | 252.13 Million | 1.93 Billion | 503.14 Million |
| Interest Expense | - | - | 25.89 Million | 9.01 Million | 6.15 Million | 1.54 Million |
| Income Tax Expense | 321.31 Million | 428.35 Million | 186.27 Million | 351.93 Million | 341.22 Million | 89.95 Million |
| Earnings before Tax | 1.74 Billion | 2.05 Billion | 1.05 Billion | 1.77 Billion | 1.92 Billion | 533.82 Million |
| Net Income | 1.4 Billion | 1.61 Billion | 830.91 Million | 1.37 Billion | 1.52 Billion | 428.06 Million |
| Earnings Per Share Basic | 0.12 | 0.14 | - | 0.02 | 0.02 | 0.04 |
| Earnings Per Share Diluted | 0.12 | 0.14 | - | 0.02 | 0.02 | 0.04 |
| Weighted Average Shares Outstanding | 11.82 Billion | 11.85 Billion | 11.87 Billion | 11.85 Billion | 11.85 Billion | 11.89 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.82 Billion | 11.85 Billion | 11.87 Billion | 11.85 Billion | 11.85 Billion | 11.89 Billion |
| Gross Margin | 0.71 | 0.72 | 0.71 | 0.71 | 0.71 | 0.70 |
| EBIT Margin | 0.27 | 0.25 | - | 0.24 | 0.25 | 0.25 |
| Profit Margin | 0.19 | 0.18 | 0.19 | 0.18 | 0.20 | 0.18 |
| EBITDA | 1.94 Billion | 2.26 Billion | - | 1.78 Billion | 1.93 Billion | 579.64 Million |
| Earnings Before Tax Margin | 0.23 | 0.23 | 0.22 | 0.03 | 0.25 | 0.22 |
TROW
605286
6023
ENTA
6626
RGLD